# Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its Mechanisms

> **NCT01046721** · NA · COMPLETED · sponsor: **University of Nottingham** · enrollment: 8 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Exenatide
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT01046721
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2018-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01046721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01046721, "Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its Mechanisms". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01046721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*